Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;19(6):868-871.
doi: 10.1016/j.jcf.2020.10.003. Epub 2020 Nov 4.

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

Collaborators, Affiliations

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

Elliot McClenaghan et al. J Cyst Fibros. 2020 Nov.

Abstract

With the growing SARS-CoV-2 pandemic, we need to better understand its impact in specific patient groups like those with Cystic Fibrosis (CF). We report on 181 people with CF (32 post-transplant) from 19 countries diagnosed with SARS-CoV-2 prior to 13 June 2020. Infection with SARS-CoV-2 appears to exhibit a similar spectrum of outcomes to that seen in the general population, with 11 people admitted to intensive care (7 post-transplant), and 7 deaths (3 post-transplant). A more severe clinical course may be associated with older age, CF-related diabetes, lower lung function in the year prior to infection, and having received an organ transplant. Whilst outcomes in this large cohort are better than initially feared overall, possibly due to a protective effect of the relatively younger age of the CF population compared to other chronic conditions, SARS-CoV-2 is not a benign disease for all people in this patient group.

Keywords: COVID-19; Coronavirus; Cystic fibrosis; SARS-CoV-2; Transplant.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors have no conflicts of interest to declare relating to this work.

References

    1. Colombo C., Burgel P.R., Gartner S., van Koningsbruggen-Rietschel S., Naehrlich L., Sermet-Gaudelus I., Southern K.W. Impact of COVID-19 on people with cystic fibrosis. Lancet Respir. 2020;8(5):E35–E36. doi: 10.1016/S2213-2600(20)30177-6. - DOI - PMC - PubMed
    1. Cosgriff R., Ahern S., Bell S.C., et al. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis. J Cyst Fibros. 2020;19(3):355–358. doi: 10.1016/j.jcf.2020.04.012. - DOI - PMC - PubMed
    1. [3]Zolin A., Orenti A., Naehrlich L., van Rens J. et al. ECFSPR Annual Report 2017. 2019. Available from: https://www.ecfs.eu/projects/ecfs-patient-registry/annual-reports
    1. Bonanad C. et al. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020;21(7):915–918. doi: 10.1016/j.jamda.2020.05.045. - DOI - PMC - PubMed
    1. Klein S.L., Dhakal S., Ursin R.L., Deshpande S., Sandberg K., Mauvais-Jarvis F. Biological sex impacts COVID-19 outcomes. PLoS Pathog. 2020 doi: 10.1371/journal.ppat.1008570. - DOI - PMC - PubMed

MeSH terms